Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Some people may naturally have beaded lines on their skin that are more visible with certain treatments, and hair loss similar to post-pregnancy can occur after specific diet and therapy.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Hair loss caused by genetics and hormones; more research needed for treatments.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Some breast cancer chemotherapy can cause permanent hair loss.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Healthy women tend to lose more hair in July and April, and the least in February.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Hair and nails are similar keratin structures with different shapes and growth, affected by the same diseases and environmental factors.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Lower growth factors linked to balding in androgenetic alopecia.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Hair loss, known as androgenic alopecia, can start in teenage years and may not always be hormone-related. It's important to do extra tests in young cases and remember it can greatly affect a teenager's mental health.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

Hormones control reproduction and are crucial for body balance.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.